Back to All Events

Hybrid Seminar

Prof. Dan S. Gombos, MD Anderson Cancer Center

Dr Gombos will provide a vision for how we will cure uveal melanoma in 2032. Following diagnosis, a liquid biopsy will be obtained providing personalized mutational status. Ocular & targeted therapy will be directed to treat micro-metastasis which will be monitored by circulating tumor cells or DNA levels.

Invited by:

The Medico Scientific Program Uveal Melanoma & SIRIC

Contact(s):

leanne.de-koning@curie.fr

Previous
Previous
November 11

Rb-NET Challenges

Next
Next
December 1

10th Annual Ocular Oncology Day